Methods and materials for reducing the risk of infections
US-9176487-B2 · Nov 3, 2015 · US
Methods and materials for reducing the risk of infections
US9775858B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9775858-B2 |
| Application number | US-201514874595-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2015 |
| Priority date | Oct 24, 2011 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This document relates to methods and materials for reducing the risk of infection after a shoulder surgery or medical procedure. For example, this document relates to methods and materials for using a topical composition containing clindamycin or erythromycin to reduce the risk of or to prevent infection associated with shoulder surgeries or medical procedures.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for reducing risk of a post-operative Propionibacterium acnes infection in a patient following a shoulder surgery, wherein said method comprises intra-operatively applying a surgical drape comprising a topical antibacterial composition to at least a portion of the operative site, wherein said topical antibacterial composition comprises clindamycin, erythromycin, or a combination thereof, and wherein said patient does not develop a post-operative Propionibacterium acnes infection from said shoulder surgery. 2. The method of claim 1 , wherein said shoulder surgery is selected from the group consisting of rotator cuff surgery, shoulder replacement surgery, instability surgery of the shoulder, clavicle fracture surgery, proximal humerus fracture surgery, and mid-shaft humerus fracture surgery. 3. The method of claim 1 , wherein said method further comprises dressing said surgical site post-operatively with dressings that are impregnated with a topical antibacterial composition comprising clindamycin.
Assignees
Inventors
Classifications
Antibacterial agents · CPC title
Biocides, antimicrobial agents, antiseptic agents · CPC title
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin} · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Medicaments · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9775858B2 cover?
- This document relates to methods and materials for reducing the risk of infection after a shoulder surgery or medical procedure. For example, this document relates to methods and materials for using a topical composition containing clindamycin or erythromycin to reduce the risk of or to prevent infection associated with shoulder surgeries or medical procedures.
- Who is the assignee on this patent?
- Mayo Foundation
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7056. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).